Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Teduglutide - 9 Meters Biopharma

Drug Profile

Teduglutide - 9 Meters Biopharma

Alternative Names: GLP-2-XTEN; NM-003; NM003 - 9 Meters Biopharma

Latest Information Update: 20 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Amunix
  • Developer 9 Meters Biopharma
  • Class Anti-inflammatories; Glucagon-like peptides; Peptides
  • Mechanism of Action Glucagon-like peptide 2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Graft-versus-host disease
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Gastrointestinal disorders

Most Recent Events

  • 20 Sep 2023 Discontinued - Preclinical for Gastrointestinal disorders in USA (SC)
  • 08 Feb 2022 Amunix has been acquired by Sanofi
  • 29 Jun 2021 9 Meters Biopharma plans IND-enabling studies for Gastrointestinal disorders, in the third quarter of 2021

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top